Native protein glycoxidation and aging

Journal of Nutrition, Health and Aging

Volumn 7, Issue 4, 2003, Pages 263-266

  Meli, M ^b   Frey, J ^b   Perier, C ^a  

^a HÔPITAL NORD   (France)

^b NONE

Author keywords

Aging; Carbohydrates; Carboxymethyllysine; Free radicals; Glycoxidation; Pentosidine

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CARBOHYDRATE; FREE RADICAL; GLUCOSE; OXYGEN; PROTEIN;

AGING; ARTICLE; CARBOHYDRATE METABOLISM; CROSS LINKING; GLYCATION; HALF LIFE TIME; OXIDATION; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN GLYCOXIDATION; PROTEIN METABOLISM; STRUCTURE ACTIVITY RELATION;

EID: 0038125611     PISSN: 12797707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Maillard L.C. Action des acides aminés sur les sucres: formation des mélanoïdes par voie méthodique. C.R. Acad. Sci. Paris 1912,154:66-68.
2. Lyons T.J., Jenkis A.J., Glycation, oxidation and lipoxydation in the development of the complications of diabetes: a carbonyl stress hypothesis. Diabetes Reviews 1997,5:365-391.
3. Sullivan R., Contribution to senescence: non-enzymatic glycation of proteins. Arch. Physiol. Biochem. 1996,104:797-806.
4. Sell D.R., Monnier V.M., Structure elucidation of a senescence crosslinking from human extracelullar matrix. Implication of pentoses in the aging process. J. Biol. Chem. 1989,264:21597-21602.
5. Bailey A.J., Sims TJ., Avery N.C., Halligan E.P., Non enzymic glycation of fibrous collagen: reaction products of glucose and ribose. Biochem. J. 1995,305:385-390.
6. Sell D.R., Lapolla A., Odetti P., Fogarty J., Monnier V.M., Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM. Diabetes 1992,41:1286-1292.
7. Kimura T., Takamatsu J., Miyata T., Miyakawa T., Horiuchi S., Localization of identified advanced glycation end-product structures, NE-(carboxymethyl)lysine and pentosidine, in age-related inclusions in human brains. Pathol. Int. 1998,48:575-579.
8. Takahashi M., Hoshino H., Kushida K., Kawana K., Inoue T., Direct quantification of pentosidine in urine and serum by HPLC with column switching. Clin. Chem. 1996,42:1439-1444.
9. Odetti P., Fogarty J., Sell D.R., Monnier V.M., Chromatographic quantification of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 1992,41:153-159.
10. Miyata T., Ishiguro N., Yasuda Y., Ito T., Nangakum M., Iwata H., Kurokawa K., Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers. Biochem. Biophys. Res. Commun. 1998,244:45-49.
11. Ahmed M.U., Thorpe S.R., Baynes J.W., Identification of Nε-(carboxymethyl)lysine as a degradation product of fructoselysine in glycated protein. J. Biol. Chem. 1986,261:4889-4894.
12. Bailey A.J., Paul R., Knott L., Mechanisms of maturation and ageing of collagen. Mech. Ageing Dev. 1998,108:1-56.
13. Fu M.X., Knecht K.J., Thorpe S.R., Baynes JW., Role of oxygen in crosslinking and chemical modification of collagen by glucose. Diabetes 1992,41:42-47.
14. Davies K., Protein damage and degradations by oxygen radicals. I.. General aspects J. Biol. Chem. 1987,262:9895-9901.
15. Glomb M., Monnier V., Mechanism of protein modification by glyoxal and glycoaldehyde reactive intermediates of the Maillard reaction. J. Biol. Chem. 1995,270:10017-10026.
16. Zu J., Morita J., Nishikawa S., Kashimura N., Generation of oxygen species by some low-molecular weight AMADORI rearrangement products under physiological conditions. Carbohydr. Lett. 1996,1:457-464.
17. Ortwerth B.J., James H., Simpson G., Linetsky M., The generation of superoxide anions in glycation reactions with sugars, osones, and 3-deoxysones. Biochem. Biophys. Res. Commun. 1998,245:161-165.
18. Monnier V.M., Toward a Maillard reaction theory of aging. Prog. Clin. Biol. Res. 1989,304:1-22.
19. Dyer D.G., Dunn J.A., Thorpe S.R., Bailie K.E., Lyons J., McCance D.R., Baynes J.W., Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J. Clin. Invest. 1993,91:2463-2469.
20. Smith M.A., Taneda S., Richey P.L., Miyata S., Yan S.D., Stem D., Sayre L.M., Monnier V.M., Perry G., Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. 1994,91:5710-5714.
21. Vitek M., Bhattacharya K., Glendening M., Stopa E., Vlassara H., Bucala R., Manogue K., Cerami A., Advanced glycation end products contribute to amyloïdosis in Alzheimer disease. Proc. Natl. Acad. Sci. 1994,91:4766-4770.
22. Horie K., Miyata T., Yasuda T., Takeda A., Yasuda Y., Maeda K., Sobue G., Kurokawa K., Immunohistochemical localization of advanced glycation end products, pentosidine and carboxymethyllysine in lipofuscine pigments of Alzheimer's disease and aged neurons. Biochem. Biophys. Res. Commun. 1997,236:327-332.
23. Sell D.R., Nagaraj R.H., Grandhee S.K., Odetti P., Lapolla A., Fogarty J., Pentosidine: a molecular marker for the cumulative damage to proteins in diabetes, aging and uremia. Diabetes Metab. Rev. 1991,7:239-251.
24. Shuvaev V.V., Laffont I., Serot J.M., Fujii J., Taniguchi N., Siest G. Increased protein glycation in cerebrospinal fluid of Alzheimer's disease. Neurobiol. Aging 2001,23:397-402.
25. Münch G., Cunningham A., Riederer P., Braak E., Advanced glycation endproducts are associated with Hirano bodies in Alzheimer disease. Brain Res. 1998,796:307-310.
26. Smith M.A., Sayre L.M., Monnier V.M., Perry G., Radical AGEing in Alzheimer disease. Trends Neurosci. 1995,18:172-176.
27. Christen Y., Oxidative stress and Alzheimer disease. Am. J. Clin. Nutr. 2000,71:621-629.
28. Rottkamp C.A., Nunomura A., Raina A.K., Sayre L.M., Perry G., Smith M.A., Oxidative stress, antioxidants and Alzheimer disease. Alzheimer Dis. Ass. Disord. 2000,14:62-66.
29. Saxena P., Saxena A.K., Cui X.L., Obrenovich M., Gudipaty K., Monnier V.M., Transition metal-catalyzed oxidation of ascorbate in human cataract extracts: possible role of advanced glycation end products. Invest. Ophthalmol. Vis. Sci. 2000,41:1473-1481.
30. Stitt A.W. Advanced glycation: an important pathological event in diabetic and age related ocular disease. Br. J. Ophtalmol. 2001,85:746-753.
31. Sell D.R., Kleinman N.R., Monnier V.M., Longitudinal determination of skin collagen glycation and glycoxidation rates predict early death in C57BL/6NNIA mice. Faseb J. 2000,14:145-156.
32. Nagai R., Matsumoto K., Ling X., Suzuki H., Araki T., Horiuchi S., Glycolaldehyde, a reactive intermediate for advanced glycation end products plays an important role in the generation of an active ligand for the macrophage scavenger receptor. Diabetes 2000,49:1714-1723.
33. Sousa M.M., Yan S.D., Stern D., Saraiva M.J., Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-κB) activation. Lab. Invest. 2000,80:1101-1110.
34. Tanaka N., Yonekura H., Yamagishi S., Fujimori H., Yamamoto Y., Yamamoto H., The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor kappa B and by 17 beta-estradiol through Sp.1 in human vascular endothelial cells. J. Biol. Chem. 2000,275:25781-25790.
35. Raj D.S., Choudhury D., Welbourne T.C., Levi M., Advanced glycation end products: a nephrologist's perspective. Am. J. Kidney Dis. 2000,35:365-380.
36. Gugliucci A., Bendayan M., Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells. Diabetologia 1996,39:149-160.
37. Shimoike T., Inoguchi T., Umeda F., Nawata H., Kawano K., Ochi H., The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy. Metabolism 2000,49:1030-1035.
38. Verbeke P., Perichon M., Friguet B., Bakala H., Inhibition of nitric oxyde synthase activity by early and advanced glycation end products in cultured rabbit proximal tubular epithelial cells. Biochim. Biophys. Acta 2000,1502:481-494.
39. Schalkwijk C.G., Ligtvoet N., Twaalfhoven H., Jager A., Blaauwgeers H.G., Schlingemann R.O., Tarnow L., Parving H.H., Stehouwer C., Van Hinsbergh V.W., Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy and localization in retinal capillaries. Diabetes 1999,48:2446-2453.
40. Teillet L., Verbeke P., Gouraud S., Bakala H., Borot-Laloi C., Heudes D., Bruneval P., Corman B. Food restriction prevents advanced glycation end product accumulation and retards kidney aging in lean rats. J. Am. Soc. Nephrol. 2000,11:1488-1497.